These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26481293)

  • 1. Comparing changes in plasma and skin autofluorescence in low-flux versus high-flux hemodialysis.
    Ramsauer B; Engels G; Arsov S; Hadimeri H; Sikole A; Graaff R; Stegmayr B
    Int J Artif Organs; 2015 Sep; 38(9):488-93. PubMed ID: 26481293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin and plasma autofluorescence during hemodialysis: a pilot study.
    Graaff R; Arsov S; Ramsauer B; Koetsier M; Sundvall N; Engels GE; Sikole A; Lundberg L; Rakhorst G; Stegmayr B
    Artif Organs; 2014 Jun; 38(6):515-8. PubMed ID: 24164288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin- and Plasmaautofluorescence in hemodialysis with glucose-free or glucose-containing dialysate.
    Ramsauer B; Engels GE; Graaff R; Sikole A; Arsov S; Stegmayr B
    BMC Nephrol; 2017 Jan; 18(1):5. PubMed ID: 28056864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.
    Meerwaldt R; Hartog JW; Graaff R; Huisman RJ; Links TP; den Hollander NC; Thorpe SR; Baynes JW; Navis G; Gans RO; Smit AJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3687-93. PubMed ID: 16280473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin Autofluorescence, a Measure of Cumulative Metabolic Stress and Advanced Glycation End Products, Decreases During the Summer in Dialysis Patients.
    Ramsauer B; Graaff R; Sikole A; Trajceska L; Lundström S; Arsov S; Hadimeri H; Stegmayr B
    Artif Organs; 2019 Feb; 43(2):173-180. PubMed ID: 30229953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of hemodialysis membrane permeability on serum levels of advanced glycation end products (AGEs) and homocysteine metabolites.
    Klemm A; Franke C; Busch M; Müller A; Franke S; Lang D; Passlick-Deetjen J; Stein G
    Clin Nephrol; 2004 Mar; 61(3):191-7. PubMed ID: 15077870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NT-proBNP and troponin T levels differ after haemodialysis with a low versus high flux membrane.
    Laveborn E; Lindmark K; Skagerlind M; Stegmayr B
    Int J Artif Organs; 2015 Feb; 38(2):69-75. PubMed ID: 25744196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the hemodialysis adequacy conducted based on low-flux polysulfone dialyzers and high-flux helixone dialyzers].
    Sobaszek-Pitas M; Kopeć J; Krzanowski M; Sułowicz W
    Przegl Lek; 2014; 71(7):384-8. PubMed ID: 25338334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of protein leaking BK-F PMMA-based hemodialysis on plasma pentosidine levels.
    Tessitore N; Lapolla A; Aricò NC; Poli A; Gammaro L; Bassi A; Bedogna V; Corgnati A; Reitano R; Fedele D; Lupo A
    J Nephrol; 2004; 17(5):707-14. PubMed ID: 15593039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of advanced glycation end products accumulation, using skin autofluorescence, in CKD and dialysis patients.
    Oleniuc M; Schiller A; Secara I; Onofriescu M; Hogas S; Apetrii M; Siriopol D; Covic A
    Int Urol Nephrol; 2012 Oct; 44(5):1441-9. PubMed ID: 22160646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of tissue advanced glycation end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal dialysis.
    Jiang J; Chen P; Chen J; Yu X; Xie D; Mei C; Xiong F; Shi W; Zhou W; Liu X; Sun S; Zhang P; Yang X; Zhang Y; Zhang Y; Liang X; Zhang Z; Lin Q; Yu Y; Miyata T; Tian J; Liang M; Luo W; Xu X; Hou F
    Atherosclerosis; 2012 Sep; 224(1):187-94. PubMed ID: 22857897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the iron metabolism and effectiveness of anemia treatment in patients on maintenance hemodialysis performed based on polysulfone and helixone dialyzers].
    Sobaszek-Pitas M; Krzanowska K; Sułowicz W
    Przegl Lek; 2014; 71(8):418-22. PubMed ID: 25546912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Examination of skin autofluorescence for the determination of glycation end-products in patients on chronic hemodialysis].
    Golubev RV; Papayan GV; Glazunova AA; Korosteleva NY; Petrishchev NN; Smirnov AV
    Ter Arkh; 2016; 88(6):65-72. PubMed ID: 27296264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
    Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
    Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphenol A in chronic kidney disease.
    Krieter DH; Canaud B; Lemke HD; Rodriguez A; Morgenroth A; von Appen K; Dragoun GP; Wanner C
    Artif Organs; 2013 Mar; 37(3):283-90. PubMed ID: 23145999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin autofluorescence advanced glycosylation end products as an independent predictor of mortality in high flux haemodialysis and haemodialysis patients.
    Nongnuch A; Davenport A
    Nephrology (Carlton); 2015 Nov; 20(11):862-7. PubMed ID: 26014842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of advanced glycation end products during haemodialysis, haemodiafiltration and haemofiltration: potential importance of dialysate quality.
    Gerdemann A; Wagner Z; Solf A; Bahner U; Heidland A; Vienken J; Schinzel R
    Nephrol Dial Transplant; 2002 Jun; 17(6):1045-9. PubMed ID: 12032195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta2-microglobulin removal and plasma albumin levels with high cut-off hemodialysis.
    Haase M; Bellomo R; Baldwin I; Haase-Fielitz A; Fealy N; Morgera S; Goehl H; Storr M; Boyce N; Neumayer HH
    Int J Artif Organs; 2007 May; 30(5):385-92. PubMed ID: 17551901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients.
    Hartog JW; Hummel YM; Voors AA; Schalkwijk CG; Miyata T; Huisman RM; Smit AJ; Van Veldhuisen DJ
    J Card Fail; 2008 Sep; 14(7):596-602. PubMed ID: 18722326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in skin autofluorescence and release of heart-type fatty acid binding protein in plasma predicts mortality of hemodialysis patients.
    Arsov S; Trajceska L; van Oeveren W; Smit AJ; Dzekova P; Stegmayr B; Sikole A; Rakhorst G; Graaff R
    Artif Organs; 2013 Jul; 37(7):E114-22. PubMed ID: 23635017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.